The relationship between electrocardiographic changes and CMR features in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy

International Journal of Cardiovascular Imaging

Volumn 30, Issue SUPPL. 1, 2014, Pages 55-63

  Chen, Xiuyu ^a   Zhao, Tao ^a   Lu, Minjie ^a   Yin, Gang ^a   Xiangli, Wei ^a   Jiang, Shiliang ^a   Prasad, Sanjay ^b   Zhao, Shihua ^a  

^a FUWAI HOSPITAL   (China)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance; Electrocardiography; Hypertrophic cardiomyopathy; Late gadolinium enhancement

Indexed keywords

GADOLINIUM PENTETATE MEGLUMINE; CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ECG ABNORMALITY; ELECTROCARDIOGRAPH; ELECTROCARDIOGRAPHY; FEMALE; FIRST DEGREE ATRIOVENTRICULAR BLOCK; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE WALL; HEART MUSCLE FIBROSIS; HEART REPOLARIZATION; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGING SOFTWARE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; Q WAVE; SEX DIFFERENCE; T WAVE; T WAVE INVERSION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; ADOLESCENT; AGED; ECHOCARDIOGRAPHY; FIBROSIS; HEART BLOCK; HEART MUSCLE; HEART STROKE VOLUME; HEART VENTRICLE; HEART VENTRICLE SEPTUM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; CONTRAST MEDIA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FIBROSIS; GADOLINIUM DTPA; HEART BLOCK; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MYOCARDIUM; STROKE VOLUME; VENTRICULAR SEPTUM; YOUNG ADULT;

EID: 84903316126     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-014-0416-x     Document Type: Article

References (36)

1. Elliott P, McKenna WJ (2004) Hypertrophic cardiomyopathy. Lancet 363(9424):1881-1891 (Pubitemid 38748646)
2. Pelliccia A, Di Paolo FM, Quattrini FM et al (2008) Outcomes in athletes with marked ECG repolarization abnormalities. N Engl J Med 358(2):152-161
3. Wilson MG, Sharma S, Carre F et al (2012) Significance of deep T-wave inversions in asymptomatic athletes with normal cardiovascular examinations: practical solutions for managing the diagnostic conundrum. Br J Sports Med 46(Suppl 1):51-58
4. Papadakis M, Carre F, Kervio G et al (2011) The prevalence, distribution, and clinical outcomes of electrocardiographic repolarization patterns in male athletes of African/Afro-Caribbean origin. Eur Heart J 32(18):2304-2313
5. Choudhury L, Mahrholdt H, Wagner A et al (2002) Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 40(12):2156-2164 (Pubitemid 36005903)
6. Alfonso F, Nihoyannopoulos P, Stewart J et al (1990) Clinical significance of giant negative T waves in hypertrophic cardiomyopathy. J Am Coll Cardiol 15(5):965-971 (Pubitemid 20104546)
7. Savage DD, Seides SF, Clark CE et al (1978) Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy. Circulation 58(3 Pt 1):402-408 (Pubitemid 9006966)
8. Dumont CA, Monserrat L, Soler R et al (2006) Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance. Eur Heart J 27(14):1725-1731 (Pubitemid 44025360)
9. Adabag AS, Maron BJ, Appelbaum E et al (2008) Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. J Am Coll Cardiol 51(14):1369-1374 (Pubitemid 351443083)
10. Konno T, Shimizu M, Ino H et al (2004) Diagnostic value of abnormal Q waves for identification of preclinical carriers of hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Eur Heart J 25(3):246-251 (Pubitemid 38235162)
11. Sato T, Nakamura K, Yamanari H et al (1998) Relationship between electrocardiographic features and distribution of hypertrophy in patients with hypertrophic cardiomyopathy. Jpn Circ J 62(7):483-488
12. Kwon DH, Smedira NG, Rodriguez ER et al (2009) Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 54(3):242-249
13. To AC, Dhillon A, Desai MY (2011) Cardiac magnetic resonance in hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 4(10):1123-1137
14. Maron MS, Maron BJ, Harrigan C et al (2009) Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 54(3):220-228
15. Bluemke DA, Yang E (2012) Hypertrophic cardiomyopathy: refining the lens of cardiac magnetic resonance to evaluate late gadolinium enhancement. J Am Coll Cardiol 60(10):930-931
16. Rudolph A, Abdel-Aty H, Bohl S et al (2009) Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 53(3):284-291
17. Chiribiri A, Conte MR, Bonamini R et al (2011) Late gadolinium enhancement and sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 57(12):1402 (author reply 1402-1403)
18. Prinz C, Schwarz M, Ilic I et al (2013) Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy. Can J Cardiol 29(3):358-363
19. Bruder O, Wagner A, Jensen CJ et al (2010) Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):875-887
20. O'Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):867-874
21. Green JJ, Berger JS, Kramer CM et al (2012) Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 5(4):370-377
22. Todiere G, Aquaro GD, Piaggi P et al (2012) Progression of myocardial fibrosis assessed with cardiac magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 60(10):922-929
23. Rowin EJ, Maron MS, Lesser JR et al (2012) CMR with late gadolinium enhancement in genotype positive-phenotype negative hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 5(1):119-122
24. Appelbaum E, Maron BJ, Adabag S et al (2012) Intermediate-signal- intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 5(1):78-85
25. Delcre SD, Di Donna P, Leuzzi S et al (2013) Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study. Int J Cardiol 167(3):1038-1045
26. Konno T, Fujino N, Hayashi K et al (2007) Differences in the diagnostic value of various criteria of negative T waves for hypertrophic cardiomyopathy based on a molecular genetic diagnosis. Clin Sci (Lond) 112(11):577-582 (Pubitemid 46849548)
27. Montgomery JV, Harris KM, Casey SA et al (2005) Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 96(2):270-275 (Pubitemid 40978588)
28. Harrigan CJ, Peters DC, Gibson CM et al (2011) Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Radiology 258(1):128-133
29. Moon JC, Fisher NG, McKenna WJ et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90(6):645-649 (Pubitemid 38668538)
30. Spirito P, Bellone P, Harris KM et al (2000) Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 342(24):1778-1785 (Pubitemid 30390237)
31. Moon JC, McKenna WJ, McCrohon JA et al (2003) Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 41(9):1561-1567 (Pubitemid 36543376)
32. Matsubara K, Nakamura T, Kuribayashi T et al (2003) Sustained cavity obliteration and apical aneurysm formation in apical hypertrophic cardiomyopathy. J Am Coll Cardiol 42(2):288-295 (Pubitemid 36851420)
33. Maron BJ, Wolfson JK, Ciro E et al (1983) Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy. Am J Cardiol 51(1):189-194 (Pubitemid 13220701)
34. Koga Y, Yamaga A, Hiyamuta K et al (2004) Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography. J Cardiovasc Electrophysiol 15(12):1402-1408 (Pubitemid 40013671)
35. Lemery R, Kleinebenne A, Nihoyannopoulos P et al (1990) Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy. J Am Coll Cardiol 16(2):368-374 (Pubitemid 20245854)
36. Elliott PM, Gimeno Blanes JR, Mahon NG et al (2001) Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy. Lancet 357(9254):420-424 (Pubitemid 32156140)